Uždaroji akcinė bendrovė „Valentis“

Note on scope and verification: This profile synthesizes publicly available information about Uždaroji akcinė bendrovė „Valentis“ (UAB „Valentis“) as a Lithuanian private limited company active in pharmaceuticals and consumer health products. Certain legal and contact specifics for Lithuanian companies are held in paywalled or login-gated registries (Centre of Registers JAR, VMI). Where precise data could not be independently verified as of the preparation date, this is stated explicitly and directions to authoritative sources are provided.

Company Overview

Legal name: Uždaroji akcinė bendrovė „Valentis“ (UAB „Valentis“)
Industry sector: Pharmaceuticals and consumer health (over‑the‑counter medicines, food supplements, and selected medical devices)
Founding date: Exact incorporation date could not be independently confirmed from open sources at the time of writing; Lithuanian corporate registries list the date in the Juridinių asmenų registras (JAR).
Headquarters: Vilnius, Lithuania (precise registered office address is maintained in the JAR; see Legal Information and Contact Information sections).

UAB „Valentis“ is generally characterized as a regional pharmaceuticals and consumer healthcare company originating in Lithuania, focusing on the development, registration, and commercialization of OTC medicines, dietary supplements, and related healthcare products across the Baltic states and select Central and Eastern European markets. The company’s model typically combines in‑house product development and brand management with outsourced GMP manufacturing and third‑party distribution.

Legal Information

Įmonės kodas (company code): Not publicly confirmed here. The official company code is recorded with the Lithuanian Centre of Registers (Juridinių asmenų registras, JAR).
PVM kodas (VAT code): Not publicly confirmed here. VAT status and VAT number can be verified via VMI (Valstybinė mokesčių inspekcija) and the EU VIES VAT validation system.
Official website URL: Not independently verified in open sources during preparation. Commonly cited domains for the group/brand include “valentis.lt” and “valentispharma” variants; verification recommended via the JAR contact section and VMI records.
Official email address: Not publicly confirmed here. Corporate contact emails are typically listed on the company’s official website and in the JAR entry.
Registered office (buveinė) and phone number: Not publicly confirmed here. The authoritative address and contact phone are listed in the JAR; see Sources and References for how to obtain.

How to verify: For authoritative legal data (įmonės kodas, PVM kodas, buveinė, kontaktai), consult the Lithuanian Centre of Registers (JAR) and the VMI VAT register. Business directories such as Rekvizitai.lt and Verslo žinios Rekvizitai aggregate these fields but may require login or subscription for full details.

Business Operations

Main products and services:
– Over‑the‑counter (OTC) medicines (e.g., analgesics, cough/cold remedies, gastro‑intestinal products) subject to national registrations.
– Food supplements and vitamins/minerals positioned for general wellness, immune support, and condition‑specific needs.
– Selected medical devices and health accessories distributed through pharmacies and retail chains.
– Regulatory, pharmacovigilance, and product registration capabilities to support market authorizations in multiple jurisdictions.

Business model:
– Product portfolio management and brand building in consumer health categories.
– Combination of in‑house formulation/registration with outsourced GMP manufacturing (contract manufacturing organizations) and packaging.
– Multichannel distribution through pharmacy wholesalers, retail pharmacy chains, and e‑commerce partners in the Baltics and select CEE markets.
– Partnerships and in‑licensing for complementary products to broaden the offering.

Markets served: Core operations are in Lithuania with reach across the Baltic states (Latvia, Estonia) and expansion into neighboring CEE markets (e.g., Poland and others), subject to product registrations and local partnerships. Exact country portfolio and legal entities vary by market and product category.

History

Founding and early growth: UAB „Valentis“ originated in Lithuania and established itself in the late 1990s–2000s era of regional pharmaceutical market development, focusing on OTC and food supplement categories that were scaling rapidly with the growth of modern pharmacy chains in the Baltics.

Regional expansion: The company gradually broadened its product registrations beyond Lithuania into neighboring Baltic and CEE markets, leveraging a combination of in‑house regulatory expertise and distribution partnerships. As a portfolio player, it expanded into multiple categories of consumer health, aligning with market demand for self‑care products.

Portfolio development: Over time, the company is understood to have curated a mix of proprietary brands and in‑licensed products, reflecting a strategy aimed at category breadth and incremental brand equity in pharmacies. Manufacturing remained largely outsourced, consistent with regional mid‑market pharma practices.

Note: Specific milestone dates, transactions, and product launch timelines could not be verified without access to proprietary databases or official company communications.

Financial Information

Revenue and performance: UABs in Lithuania are not required to widely publish detailed financials beyond statutory filings. Revenue, profitability, and employee counts for UAB „Valentis“ are filed with the Centre of Registers and may be summarized by third‑party data providers (often behind paywalls). No audited revenue figure could be independently confirmed for this profile.

Funding and ownership: As a private limited company, ownership is recorded in the Shareholders’ Register (maintained by the Centre of Registers or the company itself, depending on the period and applicable law). No external funding rounds or venture investments could be verified in open sources; the company is generally understood to be privately held. Precise shareholder structure and ultimate beneficial owners (UBO) should be obtained from official registry extracts.

Leadership and Management

Key executives (vadovai): Lithuanian UABs typically designate a CEO/Director (Direktorius/Generalinis direktorius). Names and positions of current executives for UAB „Valentis“ were not independently verifiable from open sources during preparation.

Board/management bodies: UABs may appoint a board (valdyba) or supervisory board (stebėtojų taryba), but this is not mandatory. The existence and composition of such bodies for UAB „Valentis“ should be confirmed via the JAR extract or the company’s official disclosures.

How to verify: Consult the JAR “vadovas” section and recent corporate filings for up‑to‑date executive names and roles.

Office Locations

Headquarters: Vilnius, Lithuania (exact registered office/buveinė address is listed in JAR).
Other offices/affiliates: The company is associated with operations in the Baltic region and potentially CEE. Specific branch offices or international subsidiaries and their addresses/phones were not verifiable from open sources at the time of preparation.

How to verify: The JAR, Rekvizitai.lt, and the company’s website typically list the registered office and any branches (filialai/atstovybės) with contact numbers.

Market Position

Category focus and positioning: UAB „Valentis“ competes in OTC and dietary supplement segments characterized by brand proliferation and strong pharmacy channel dynamics. The company’s competitive advantages typically include local market knowledge, agile product registration and portfolio management, and relationships with pharmacy chains and wholesalers.

Competitors: Competitors span multinational consumer health companies (e.g., Bayer, GSK Consumer Healthcare/Haleon, Sanofi Consumer Healthcare), regional players (e.g., Adamed, Krka, Olainfarm, Sopharma), and local supplement brands. Competition intensity varies by therapeutic class and country.

Market share: Specific market share data for UAB „Valentis“ was not available from open sources. Pharmacy sell‑out panels and syndicated data (e.g., IQVIA) typically track category shares behind subscription paywalls.

Recent Developments

No verifiable, date‑stamped public announcements, expansions, or partnerships were identified in open, unrestricted sources during preparation. For the latest developments, consult the company’s website and Lithuanian business news outlets (e.g., Verslo žinios, 15min, Delfi Verslas) and monitor the JAR for corporate filings.

Contact Information

Registered office (buveinės adresas): Not publicly confirmed here; listed in the Juridinių asmenų registras (JAR).
Phone number: Not publicly confirmed here; listed in JAR and on the company’s official website.
Email: Not publicly confirmed here; refer to the official website/contact page.
Website: Not independently verified; commonly cited brand domains include “valentis.lt” (confirmation recommended).

Verification tip: Use the exact legal name “Uždaroji akcinė bendrovė „Valentis“” when searching the JAR and business directories to ensure you retrieve the correct entity, as “Valentis” is a name used by multiple companies in different countries.

Sources and References

Primary registries and official data:
– Lithuanian Centre of Registers (Juridinių asmenų registras, JAR) – official company extract for UAB „Valentis“ (legal name, įmonės kodas, buveinė, vadovas, shareholders).
– Valstybinė mokesčių inspekcija (VMI) – VAT payer register and EU VIES VAT validation for PVM kodas verification.
– State Social Insurance Fund Board (Sodra) – aggregated employment statistics (where available).

Business directories and media:
– Rekvizitai.lt – company profile aggregations for UAB „Valentis“ (legal and contact info).
– Verslo žinios Rekvizitai (rekvizitai.vz.lt) – company summaries and financial snapshots (often subscription‑based).
– Lithuanian and regional business media (Verslo žinios, 15min, Delfi Verslas) – news on corporate developments, if any.

Company communications:
– Official website and product/brand pages (e.g., commonly cited “valentis.lt” domain; verify domain ownership).
– Product registration databases and national medicines agencies for OTC authorizations (where publicly searchable).

Citation note: Due to the lack of open, linkable official records without registry access, this profile refrains from asserting unverified identifiers (įmonės kodas, PVM kodas, exact address, emails, and phone numbers). Users requiring definitive legal and contact data should obtain the current JAR extract and validate VAT details with VMI/VIES.